Skip to content
GLP-1 Scorecard
Menu
Graded #247

PeptidesRx

PeptidesRx is a Fort Worth, TX-based licensed telehealth platform offering physician-supervised compounded semaglutide, tirzepatide, and a broader prescription peptide menu.

Visit PeptidesRxWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$169/mo (0.25 mg dose, compounded)
Tirzepatide
$309/mo (2.5 mg dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh PeptidesRx against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because PeptidesRx dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value61/100
Dose & formulation54/100
Clinical oversight85/100
Labs & monitoring55/100
Fulfillment70/100
Contract terms55/100

Strengths

  • Compliance-focused positioning vs gray-market vendors
  • Board-certified medical director
  • Transparent pricing with no surprise fees
  • Real prescriptions, not research-chemical channel

Where it loses points

  • Smaller scale than Henry Meds or Hims
  • Wide peptide menu may distract from GLP-1 focus

Bottom line — Grade C

Best for: Patients prioritizing regulatory compliance in the compounded space.

Ranked #247 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest PeptidesRx — the realistic shortlist.

The 20 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect PeptidesRx's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on PeptidesRx's site. Not medical advice; see our disclosure.

← Back to the scorecard